Case Report: ICIs-induced Guillain–Barré syndrome recovered from mycophenolate mofetil

The emergence of immune checkpoint inhibitors (ICIs) has significantly prolonged the survival time of cancer patients. However, it may also lead to various immune-related adverse events (irAEs), including Guillain–Barré syndrome (GBS), a rare type of irAE. Most GBS patients can recover spontaneously...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Mengge, Deng, Chao, Liu, Xianling, Jiang, Shun, Gao, Yuan, Fan, Dan, Zhou, Yiguang, He, Jiangbo, Liu, Chaoyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10200921/
https://www.ncbi.nlm.nih.gov/pubmed/37223099
http://dx.doi.org/10.3389/fimmu.2023.1132692

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10200921/
https://www.ncbi.nlm.nih.gov/pubmed/37223099
http://dx.doi.org/10.3389/fimmu.2023.1132692

Ejemplares similares